Cetuximab in the treatment of head and neck cancer

J Bernier - Expert review of anticancer therapy, 2006 - Taylor & Francis
Approaches to the treatment of locally advanced and recurrent and/or metastatic squamous
cell carcinoma of the head and neck (SCCHN) have been limited by their toxicity. Effective …
被引用次数：61 相关文章

Cetuximab in the treatment of head and neck cancer

J Bernier - Expert review of anticancer therapy, 2006 - pubmed.ncbi.nlm.nih.gov
Approaches to the treatment of locally advanced and recurrent and/or metastatic squamous
cell carcinoma of the head and neck (SCCHN) have been limited by their toxicity. Effective …

Cetuximab in the treatment of head and neck cancer

J Bernier - Expert Review of Anticancer Therapy, 2006 - go.gale.com
Cancers of the head and neck (comprising cancers of the oral cavity, pharynx and larynx)
account for over 5% of all malignancies worldwide [1]. In 2002, there were over 500,000 new …

Cetuximab in the treatment of head and neck cancer.

J Bernier - Expert Review of Anticancer Therapy, 2006 - europepmc.org
Approaches to the treatment of locally advanced and recurrent and/or metastatic squamous
cell carcinoma of the head and neck (SCCHN) have been limited by their toxicity. Effective …

Cetuximab in the treatment of head and neck cancer

J Bernier - Expert Review of Anticancer Therapy, 2006 - search.proquest.com
Approaches to the treatment of locally advanced and recurrent and/or metastatic squamous
cell carcinoma of the head and neck (SCCHN) have been limited by their toxicity. Effective …

[引用][C] Cetuximab in the treatment of head and neck cancer

J BERNIER - Expert review of anticancer therapy, 2006 - pascal-francis.inist.fr
Cetuximab in the treatment of head and neck cancer CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …

[引用][C] Cetuximab in the treatment of head and neck cancer

J BERNIER - Expert review of anticancer therapy, 2006 - Future Drugs